News

11.05.2021 - TP ICAP Midcap Annual Conference

Valbiotis participates, in virtual, at the 8th edition of TP ICAP/Midcap Annual Conference to discuss with investors about the acceleration of its development.

22.01.2021 - Biomed Event – Invest Securities

Sébastien PELTIER, CEO, and Jocelyn PINEAU, CFO, participate in the Biomed Event on January 26 and 27, 2021, organized by Invest Securities.

11.01.2021 - J.P. Morgan Healthcare Conference / H.C. Wainwright BioConnect Conference

VALBIOTIS participates in the 39th J.P. Morgan Healthcare annual conference as well as in H.C. Wainwright BioConnect from January 11-14, 2021, in virtual format.

02.12.2020 - French Healthcare Days Mexico

VALBIOTIS is participating in the French Healthcare Days Mexico 2020, on December 2 and 3, organized by Business France Mexico, to discuss the challenges of metabolic diseases.

18.11.2020 - Journées Aliments & Santé

VALBIOTIS takes part in the Food & Health Days organized by the CRITT Agro-Alimentaire of Nouvelle-Aquitaine, where Sébastien PELTIER (CEO) discusses the needs for the prevention of metabolic diseases during a conference.

12.11.2020 - Wainwright 6th Annual Israel Conference

Sébastien PELTIER (CEO) and Jocelyn PINEAU (CFO) attend the 6th Annual Israel Conference in Wainwright to meet investors.

10.11.2020 - Forum CM-CIC

Sébastien PELTIER (CEO) and Jocelyn PINEAU (CFO) participate in the 7th edition of the CIC Market Solutions Forum, organized by CM-CIC.

26.10.2020 - Galien week of innovation

VALBIOTIS participates in the Galien Week of Innovation, 5 days dedicated to exhilirating online discussions and debates focused on global health and announcements of the Prix Galien Awards 2020 winners, by Galien Foundation.

19.10.2020 - Large & Midcap Event – Invest Securities

VALBIOTIS participates in the 20th edition of the Large MidCap Event, organized by Invest Securities, on October 19 and 20, 2020.

05.10.2020 - Healthtech Innovation Days

VALBIOTIS is participating, on October 5 and 6, in the 2nd edition of Healthtech Innovation Days, the event that stimulates and promotes collaborations within European ecosystems of health and life sciences, organized by France Biotech.

01.10.2020 - Biotech Santé Seminar – Portzamparc

VALBIOTIS participates in the Biotech Health seminar, organized in Portzamparc, on October 1, 2020.

29.09.2020 - Nutriform Business Days

VALBIOTIS participates in Nutriform Business Days, where Murielle CAZAUBIEL, Director of Development and Medical Affairs, speaks for a conference on prediabetes.

21.09.2020 - Annual Meeting of the European Association for the Study of Diabetes (EASD)

VALBIOTIS selected to present 3 studies on TOTUM-63 by the European Association for the Study of Diabetes (EASD), from 21 to 25 September, 2020.

12.06.2020 - 80th scientific sessions of the American Diabetes Association

VALBIOTIS to present Phase II clinical results of TOTUM-63 in prediabetes at the 2020 scientific sessions of the American Diabetes Association, June 12-16 (in virtual format, due to the COVID-19 health crisis).

11.02.2020 - Investor meetings – Portzamparc

Sébastien PELTIER and Jocelyn PINEAU invited by Portzamparc, to meet investors, in Paris.

28.01.2020 - Biomed Event

Sébastien PELTIER and Jocelyn PINEAU meet investors at the Biomed Event, organized by Invest Securities, in Paris.

16.10.2019- French Society of Financial Analysts (SFAF)

Exchanges around the new strategic priorities of the company presented by Sébastien PELTIER and Jocelyn PINEAU at the SFAF in Paris.

14.10.2019 - European Large and MidCap Event

Sébastien PELTIER and Jocelyn PINEAU present the company’s new strategic priorities for investors at the Large & Midcap Event, organized by Invest Securities in Paris.

16.09.2019 - Annual Meeting of the European Association for the Study of Diabetes (EASD)

Presentation of the positive results of a study on TOTUM-63 carried out by the CarMeN laboratory in Lyon.

10.09.2019 - Seminar Biotech Portzamparc

Meetings between investors and leaders of Biotech / Health listed companies during a day dedicated to the sector.

24.06.2019 - Health Tech Investors Days 2019

VALBIOTIS is attending the 2019 Health Tech Investors Day, an international event organized by France Biotech and placed under the high patronage of Mr. Emmanuel MACRON, June 24/25 in Paris.

07.06.2019 - 79th scientific sessions of American Diabetes Association

VALBIOTIS to present novel data about TOTUM-63 and metabolic diseases prevention at the 2019 scientific sessions of the American Diabetes Association, June 7-11, in San Francisco (California).

06.06.2019 - Dietecom

VALBIOTIS is present at Dietecom, the practical nutrition days from June 6th to 7th, in Paris (France).

23.05.2019 - F2iC / Champeil / Boursier.com

Sébastien PELTIER (CEO) et Jocelyn PINEAU (CFO) meet shareholders and private investors organized by F2iC, Champeil and Boursier.com, in Bordeaux (France).

17.04.2019 - Small Cap Event Invest Securities

Sébastien PELTIER (CEO) and Jocelyn PINEAU (CFO) meet investors at Small Cap Event organized by Invest Securties, in Paris (France)

10.04.2019 - MidCap Portzamparc Conference

Sébastien PELTIER (CEO) and Jocelyn PINEAU (CFO) meet investors at the 6th edition of the MidCap Conference 2019 organized by Portzamparc, in Paris (France).

04.04.2019 - Market Solutions Forum

Sébastien PELTIER (CEO) et Jocelyn PINEAU (CFO), participate in the Market Solutions Forum organized by CM-CIC Market Solutions, April 4 and 5, in Paris (France).

26.03.2019 - Biotech Agora

VALBIOTIS’ management team presents the advances of the company at a BiotechAgora night meeting, Paris (France), on March 26, 2019.

25.03.2019 - F2ic meeting

VALBIOTIS’ management team meets private individual investors at F2iC meeting, Paris (France), on March 25, 2019.

15.03.2019 - Les Echos : Maladie de civilisation recherche prévention efficiente

05.02.2019 - Biotech Day

Sébastien PELTIER (CEO) & Jocelyn PINEAU (CFO) take part in Biotech Day by SFAF, Paris (France).

22.01.2019 - Biomed Event

Sébastien PELTIER and Jocelyn PINEAU presents the VALBIOTIS’ milestones for 2019 at Biomed Event by Invest Securities, Paris (France).

07.01.2019 - J.P. Morgan Healthcare Conference

VALBIOTIS is taking part in the 37th J.P. Morgan Healthcare conference, from 7 to 10 January 2019 in San Francisco, California.

28.11.2018 - Journées Francophones de Nutrition

VALBIOTIS at Journées Francophones de Nutrition from 28 to 30 November, in Nice (France).

09.11.2018 - American Association for the Study of Liver Diseases Congress

VALBIOTIS at the AASDL Liver Meeting from 9 to 13 November, in San Francisco.

09.10.2018 - European Large & Midcap Event

VALBIOTIS at European Large & Midcap Event, in Paris (France), from Octobre 8 to 9, 2018.

03.10.2018 - European Association for the Study of Diabetes (EASD) Congress

VALBIOTIS presents its data on the multi-target mode of action of TOTUM-63, active principle of VALEDIA®, on October 4, 2018 (poster).

27.09.2018 - 100 portraits beyond diabetes

This unique operation is based on sharing the experience of 100 individuals, living or not with diabetes, of all ages and all professions: entrepreneurs, young creatives, sportsmen and women, students, artists, associations leaders but also healthcare professionals such as physicians, nurses, nutritionists, etc. 100 volunteers who actively shed light to their job or remarkable action in the field of diabetes.

Through this original experience, Abbott, committed in diabetology for more than 20 years alongside of experts, healthcare professionals, associations and patients, aims at showing that an active and full life is possible beyond diabetes.

Know more: www.100portraits.fr

An advisory committee participated in selecting 100 candidates: Pr Serge Halimi – diabetologist, Dr Claude Colas – diabetologist, Dr Dominique Pierrat – Top Santé editor in chief and Solange Arnaud, founder of the medoucine.com start-up.

All texts published aside the photo of each person involved in the project were written under their own responsibility.

05.09.2018 - Biotech Santé Portzamparc Conference

VALBIOTIS at Biotech Santé Portzamparc Conference in Paris (France), September 5, 2018.

22.08.2018 - French Startup Cup 2018

VALBIOTIS at French Startup Cup 2018 in La Rochelle (France), from August 24 to 26, 2018.

03.07.2018 - « Journée nutrition » SFAF

VALBIOTIS at « Journée nutrition » SFAF in Paris (France), July 3, 2018.

27.06.2018 - Midcap spring european event

VALBIOTIS at Midcap spring european event in Paris (France), from June 27 to 28, 2018.

19.06.2018 - Journées Aliments & Santé 2018

VALBIOTIS at Journées Aliments & Santé à La Rochelle (France), from June 20 to 21 juin, 2018.

04.06.2018 - BIO International Convention 2018

VALBIOTIS at Bio International Convention in Boston (Massachusetts, USA), from June 4 to 7, 2018.

11.04.2018 - International Liver Congress 2018

VALBIOTIS at EASL International Liver Congress in Paris (France),

02.04.2018 - Portzamparc Midcap Conference

VALBIOTIS at Portzamparc Midcap Conference in Paris (France), from April 4 to 5, 2018.

13.03.2018 - BIO-Europe Spring 2018

VALBIOTIS at the BIO-EUROPE SPRING in Amsterdam (Netherlands), from March 12 to 14, 2018.

05.03.2018 - Keystone symposium: Manipulation of Gut Microbiota for Metabolic Health

VALBIOTIS at the Keystone Symposia in Banff (Canada), from March 4 to 8, 2018.

07.01.2018 - JP Morgan Healthcare Conference 2018

Sébastien PELTIER, CEO, and Jocelyn PINEAU, CFO, invited at JP Morgan Health Conference in San Francisco (California, USA), from January 8 to 11, 2018.

13.12.2017 - Journées Francophones de Nutrition 2017

VALBIOTIS at Journées Francophones de Nutrition in Nantes (France), from December 13 to 15, 2017.

06.11.2017 - BIO-Europe 2017

VALBIOTIS at the BIO EUROPE in Berlin (Germany), from November 6 to 8, 2017.

16.10.2017 - CPHI Worldwide 2017

VALBIOTIS at the CPhI worldwide in Frankfurt (Germany), from October 24 to 26, 2017.

14.06.2017 - International BIO Convention 2017

VALBIOTIS at the International BIO Convention in San Diego (California, USA) from June 19 to 22, 2017.

12.06.2017 -77th scientific sessions of American Diabetes Association 2017

VALBIOTIS presents the results of its phase I/II clinical trial to evaluate TOTUM-63 (active ingredient of Valedia®) for managing prediabetes at the 77th scientific sessions of American Diabetes Association – San Diego Convention Center, San Diego (California, USA), from June 9 to 13, 2017.

21.03.2017 -Congress of the Société Francophone du Diabète 2017

VALBIOTIS at the Congress of the Société Francophone du Diabète in Lille (France), from March 28 to 31, 2017. The VALBIOTIS team presents its results: “TOTUM-63 (active ingredient of Valedia®) improves insulin sensitivity and limits fat intake in mice fed a high-fat diet.”

21.02.2017 - BIO Europe Spring 2017

VALBIOTIS at the BIO SPRING in Barcelona (Spain), from March 20 to 22, 2017.

22.01.2017 - Keystone Symposium

Yolanda Fernandez Otero (Blaise Pascal University) at the Keystone Symposia (Colorado, USA), from January 22 to 26, 2017.
She presents the work carried out on a new botanical complex created and developed by VALBIOTIS, which improves obesity on obese (ob/ob) and diabetic (db/db) mice.

30.06.2016 - VALBIOTIS in DIABETES

First publication for VALBIOTIS in the international scientific journal Diabetes : “A New Botanical Complex Improves Blood Glycemic Control and Reduces Hepatic Steatosis in Mice” (628-P).
Preclinical results obtained by our T2D preventive solution Valedia® from the active ingredient TOTUM-63. These results were presented at the American Diabetes Association, 76th Scientific Sessions, New Orleans (Louisiana, USA). Diabetes is the referent of international scientific journal about diabetes and lists numerous scientific publications on the pathology.

27.05.2016 - VALBIOTIS in La Tribune

VALBIOTIS, in French economic national newspaper La Tribune: “Valbiotis, la start-up française qui veut tuer le diabète dans l’oeuf”.

19.05.2016 - 76th scientific sessions of American Diabetes Association 2016

VALBIOTIS is selected for the American Diabetes Association, 76th scientific sessions, New Orleans (Louisiana, USA). Sébastien PELTIER and VALBIOTIS’ scientific team will present our T2D preventive solution preclinical results, on June-11, 11.30 AM, at the Ernest N.Morial Convention Center.

17.05.2016 - International BIO Convention 2016

VALBIOTIS at the International BIO Convention in San Francisco (California, USA) from June 6 to 9, 2016. With the financial support of the region Aquitaine Limousin Poitou-Charentes.

03.03.2016 - Congress of the Société Francophone du Diabète

A part of our preclinical trials realised for TOTUM-63, active ingredient of VALEDIA®, our product for type 2 diabetes prevention, has been selected for the next “french speaking society of Diabetes” congress that will take place in Lyon (France), 22-25 march. Those works named: «Valedia®, a new candidate for AMPK regulation and type 2 Diabetes prevention”, show how Valedia® limits T2D development on db/db mice using a cellular mechanism that involve AMPK, a key enzyme of metabolism.

01.07.2015 - I-Lab prize for VALBIOTIS

VALBIOTIS won the french ministry of research prize for innovation I-LAB 2015. VALBIOTIS presented its innovative products to the jury, and mainly its type 2 solution for diabetes prevention.

15.06.2015 - International BIO Convention 2015

VALBIOTIS participate in Bio International Convention in Philadelphia (Pennsylvania, USA), from June 15-18, 2015. The right place to meet clients and partners involved in the pharmaceutical industry, interested in innovation and dicover the last market trends.

16.04.2015 - VALBIOTIS in Challenges

“Challenges” magazine selected VALBIOTIS in its TOP 100 of start-up to invest in. VALBIOTIS’ innovative products and expertise, convinced “Challenges” to include the young french company in its list.

May 11, 2021
- News

TP ICAP Midcap Annual Conference

Read more

January 22, 2021
- News

Biomed Event – Invest Securitie

Read more

January 11, 2021
- News

J.P. Morgan Healthcare Conference / H.C. Wainwright BioConnect Conference

Read more